iSCLife®-OA (hUC Mesenchymal Stem Cell Therapy)

human umbilical cord-derived mesenchymal stem cells · Sclnow Biotechnology Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for iSCLife®-OA (hUC Mesenchymal Stem Cell Therapy), covering 2025-12-04 to 2025-12-04. Get the full timeline:

Most recent: Clinical Trial Update: The Safety/Efficacy of hUC Mesenchymal Stem Cells（19#iSCLife®-OA） Therapy for Patients With Osteoarthritis [Phase 2]

See pricing